Found 391 matching trials
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
PHASE2This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Location
Multiple Locations
Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients
PHASE1This first-in-human open-label, multi center, dose-escalation and expansion...
Location
Liverpool Hospital
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ยฑ Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
PHASE1This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Location
Peking Union Medical College Hospital
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
PHASE2The aim of the study is to determine if intervening with combined local the...
Location
Fudan Universtiy Shanghai Cancer Center
Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
PHASE2The aim of this study is to develop an adaptive radiation therapy plan for ...
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer
PHASE2This is a phase II clinical study evaluating the safety, tolerability, phar...
Location
SunYat-sen University Cancer Center
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
PHASE1Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Location
the First Affiliated Hospital of Zhengzhou University
CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor
PHASE1This is a single-arm, open-label, one center clinical study, to determine t...
Location
Ningbo No.5 Hospital (Ningbo Cancer Hospital)
Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
PHASE2Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Location
Tangdu Hospital, Fourth Military Medical University
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial
PHASE3This is a randomized, controlled clinical trial based on prior exploratory ...
Location
Guangdong Provincial People's Hospital